OBS Group is one of the top pharmaceutical players amongst 695 companies with a strong presence in Pakistan and Sri Lanka. It is among the very few companies in Pakistan which has specialized in developing strategic business alliances with reputed international firms like Organon, Merck & Co. Inc. USA and Schering Plough. OBS Group has achieved these strategic alliances by providing a full range of high quality professional services encompassing manufacturing, marketing and sales of pharmaceutical and consumer health products.
Currently OBS Group operates via two companies i.e. AGP and Aspin Pharma under the umbrella of Aitkenstuart / OBS Healthcare Pakistan.
History & Heritage
Organon (now OBS Healthcare) was acquired by Mr. Tarek Khan in 2006 via a management buyout. The company has a topline of PKR 260mn at the time of acquisition.
OBS launched its generic division by the name of OBS Pharma to specialize in a variety of first line therapeutics
OBS took over Merck Sharp & Dohme Pakistan Ltd.’s operations and manufacturing along with its major brands thereby developing a strategic partnership with Merck & Co. Inc. USA.
OBS acquired several MSD brands in Sri Lanka via further alliance with Merch & Co. Inc. USA. This was the Group’s first international venture and it set the tone for future expansion.
Aklima Clinical Research was established to usher a new era of clinical research and trial management in Pakistan. The center partnered with Norton Audits Inc. USA to develop skilled clinical researchers.
OBS acquired Schering Plough Business from MSD
OBS acquired AGP (Pvt.) Ltd. and AGP Healthcare (Pvt.) Ltd. along with its products and generic brands. This was a strategic move to enter the generic market for future growth.
OBS acquired Janssen, the pharmaceutical division of Johnson & Johnson Pakistan along with its major brands. The business was subsequently renamed Aspin Pharma.
OBS strategic alliance with Mylan (USA) to offer Mylan products. These products are marketed by AGP.
OBS strategic alliance with Santen (Japan) to offer Santen Products.
OBS strategic alliance with Vifor (Switzerland) to offer Vifor products In Pakistan.
AGP Limited, has been listed on the Pakistan Stock Exchange with the market capitalization of ~ USD 220 Mn
OBS acquired two brands of GSK from Aspen Pharma, South Africa.
OBS divested MSD, Vifor, Santen, Schering Plough, Portfolio
OBS-AGP is setup to acquire Sandoz products in Pakistan
Strategic Alliances with Other Research MNCs looking for business solutions
Introduction of Potential Generic Products:
- Strategic Alliances with Research MNCs which are focusing on their own line of branded generics.
- Strategic Alliance with strong branded generic companies globally.
- Major player in Population Control / Contraceptives
Introduction of Consumer Health Portfolio :
- Medical Devices
- Wound Management
- Home care
- Vitamins / Nutraceuticals
- Personal Care
CONTRACT/ LICENSE MANUFACTURING
High-quality Manufacturing Plant
Continuous investment in up-gradation of our manufacturing facilities for complying with SRA standards and to provide high-quality license / contract manufacturing to other MNCs in Pakistan.
Expand OBS Presence in the Region
- Offshore Business Alliances with our strategic partners.
- Expand our business in Sri Lanka & other ASEAN Countries
- Develop OBS portfolio in Afghanistan, Far East Countries (Vietnam, Myanmar, Philippines & Malaysia) Former CIS estates (Uzbekistan, Tajikistan, etc.) and West Africa.
To emerge as a “Total Health Care Solutions Provider” by entering in:
- Consulting Clinics & Hospital Chain
- Pharmacy chain
- Basic Manufacturing
- Further enhance our capabilities of clinical research organization (Aklima)